statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Exact Sciences schedules second quarter 2024 earnings call

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its second quarter 2024 financial results after the...

Exact Sciences to Participate in June Investor Conferences

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited...

Futures Rebound After Thursday Rout As Rate Cut Expectations Fade

Futures Rebound After Thursday Rout As Rate Cut Expectations Fade

 After Thursday's rout, which saw the overbought S&P first hit an all time high before traders suddenly dumped...

Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, will present 10 abstracts highlighting the breadth and depth of the companys screening and diagnostic...

Exact Sciences Earns 2024 Great Place To Work Certification

Exact Sciences (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today that the company has been certified as a 2024 Great Place To Work for the sixth consecutive...

Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that a District Court judge denied in part Geneoscopys (defendant) motion to dismiss...

Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Exact Sciences Stock Plunges On Q1 Earnings: What You Need To Know

Exact Sciences said first-quarter revenue increased 6% year-over-year to $638 million, which beat the consensus estimate of $627.355 million, according to Benzinga Pro. The company reported a...

Exact Sciences Stock, A Cathie Wood Darling, Tumbles On Wide Quarterly Losses

Exact Sciences Stock, A Cathie Wood Darling, Tumbles On Wide Quarterly Losses...

Exact Sciences Announces First-Quarter 2024 Results

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company generated revenue of $638 million for the first quarter ended March...

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Volume	3.75M
52-Wk High	$99.56
52-Wk Low	$40.62

EXAS Exact Sciences Corp.

About

Feed

News

Sentiment

Earnings

Fundamentals